Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre studyAntoine Desîlets, Arielle Elkrief, Wiam Belkaïd et al.|European Journal of Cancer|2020Cited by 78
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C. M. Lau, Adrian G. Sacher, Malcolm Ryan et al.|JTO Clinical and Research Reports|2021Cited by 11
Identification of immunotherapy early treatment failure in non-small cell lung cancer (NSCLC) using a novel cell-free DNA (cfDNA) tissue-agnostic genome-wide methylome enrichment assay.Tuan Hoang, Adrian G. Sacher, Yahan Yang et al.|Journal of Clinical Oncology|2025Cited by 1